ArticleClinical kidney journal2021

Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis.

Alberto Ortiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.